Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-nasal Naloxone for Impaired Awareness of Hypoglycemia
NCT02700048Phase 2Terminated
- Sponsor
- University of Minnesota
- Start
- Jun 2016
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of naloxone in Hypoglycemia unawareness (HU), sponsored by University of Minnesota. Started Jun 2016; status: terminated.
02
Drugs
naloxone
03
Conditions
Hypoglycemia unawareness (HU)
Beyond the preview
Go deeper on NCT02700048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02700048.